簡報平台

簡報平台

歡迎來到簡報平台，您可以透過我們龐大的教育投影片平台製作簡報，並進行編輯、儲存及輸出客製化內容。

請輸入至少 3 個字母
Featured
最新

推薦內容

COVID-19 and its implications in heart failure
簡報
COVID-19 and its implications in heart failure
觀看內容
Can new-onset diabetes be prevented
簡報
Can new-onset diabetes be prevented
觀看內容
Practicalities of SGLT2 inhibition – pros vs cons
資訊圖表
Practicalities of SGLT2 inhibition – pros vs cons
觀看內容
Updates on ESC heart failure guidelines
影片
Updates on ESC heart failure guidelines
觀看內容
Cardiologist Practical Guide to Prescribing
資訊圖表
Cardiologist Practical Guide to Prescribing
觀看內容
Cardiovascular
最新

心血管

Mechanisms behind the cardiovascular benefits of SGLT2 inhibitors
簡報
Mechanisms behind the cardiovascular benefits of SGLT2 inhibitors
觀看內容
What did the study tell us about the safety of medicines in heart failure?
簡報
What did the study tell us about the safety of medicines in heart failure?
觀看內容
Hiding in plain sight – how to detect heart failure in primary care
簡報
Hiding in plain sight – how to detect heart failure in primary care
觀看內容
Optimizing HF discharge care and follow-up
簡報
Optimizing HF discharge care and follow-up
觀看內容
查看全部心血管相關簡報
Infection and Vaccines
最新

COVID-19

What did the study tell us about the safety of medicines in heart failure?
簡報
What did the study tell us about the safety of medicines in heart failure?
觀看內容
The benefits of SGLT2 inhibitors in type-2 diabetes, chronic kidney disease and heart failure
簡報
The benefits of SGLT2 inhibitors in type-2 diabetes, chronic kidney disease and heart failure
觀看內容
Managing type 2 diabetes beyond glycemia: cardiorenal risk in T2D
簡報
Managing type 2 diabetes beyond glycemia: cardiorenal risk in T2D
觀看內容
Chronic kidney disease management
簡報
Chronic kidney disease management
觀看內容
查看全部COVID-19相關簡報
Metabolic
最新

代謝疾病

Managing Type 2 Diabetes Beyond Glycemia : Cardiorenal risk in T2D
簡報
Managing Type 2 Diabetes Beyond Glycemia : Cardiorenal risk in T2D
觀看內容
The benefits of SGLT2 inhibitors in type-2 diabetes, chronic kidney disease and heart failure
簡報
The benefits of SGLT2 inhibitors in type-2 diabetes, chronic kidney disease and heart failure
觀看內容
Clinical recommendations for the management of type 2 diabetes
簡報
Clinical recommendations for the management of type 2 diabetes
觀看內容
Managing type 2 diabetes beyond glycemia: cardiorenal risk in T2D
簡報
Managing type 2 diabetes beyond glycemia: cardiorenal risk in T2D
觀看內容
查看全部代謝疾病相關簡報
Oncology
最新

腫瘤醫學

What did the study tell us about the safety of medicines in heart failure?
簡報
What did the study tell us about the safety of medicines in heart failure?
觀看內容
Hiding in plain sight – how to detect heart failure in primary care
簡報
Hiding in plain sight – how to detect heart failure in primary care
觀看內容
Kidney outcomes associated with inhibition of SGLT2
簡報
Kidney outcomes associated with inhibition of SGLT2
觀看內容
Medicines in chronic kidney disease
簡報
Medicines in chronic kidney disease
觀看內容
查看全部腫瘤醫學相關簡報
Renal
最新

腎臟疾病

Chronic kidney disease management
簡報
Chronic kidney disease management
觀看內容
Renal protection with SGLT2 inhibitors: what every cardiologist should know
簡報
Renal protection with SGLT2 inhibitors: what every cardiologist should know
觀看內容
Kidney outcomes associated with inhibition of SGLT2
簡報
Kidney outcomes associated with inhibition of SGLT2
觀看內容
Medicines in chronic kidney disease
簡報
Medicines in chronic kidney disease
觀看內容
查看全部腎臟疾病相關簡報
Respiratory and Immunology
最新

呼吸道及免疫疾病

What did the study tell us about the safety of medicines in heart failure?
簡報
What did the study tell us about the safety of medicines in heart failure?
觀看內容
Hiding in plain sight – how to detect heart failure in primary care
簡報
Hiding in plain sight – how to detect heart failure in primary care
觀看內容
Clinical recommendations for the management of type 2 diabetes
簡報
Clinical recommendations for the management of type 2 diabetes
觀看內容
Managing type 2 diabetes beyond glycemia: cardiorenal risk in T2D
簡報
Managing type 2 diabetes beyond glycemia: cardiorenal risk in T2D
觀看內容
查看全部呼吸道及免疫疾病相關簡報
Rare Disease
最新

罕見疾病

Mechanisms behind the cardiovascular benefits of SGLT2 inhibitors
簡報
Mechanisms behind the cardiovascular benefits of SGLT2 inhibitors
觀看內容
Hiding in plain sight – how to detect heart failure in primary care
簡報
Hiding in plain sight – how to detect heart failure in primary care
觀看內容
The benefits of SGLT2 inhibitors in type-2 diabetes, chronic kidney disease and heart failure
簡報
The benefits of SGLT2 inhibitors in type-2 diabetes, chronic kidney disease and heart failure
觀看內容
Managing type 2 diabetes beyond glycemia: cardiorenal risk in T2D
簡報
Managing type 2 diabetes beyond glycemia: cardiorenal risk in T2D
觀看內容
查看全部罕見疾病相關簡報
Featured
最新

熱門內容

The story of heart failure prevention with SGLT2 inhibitors in diabetes: Key learnings for cardiologist
簡報
The story of heart failure prevention with SGLT2 inhibitors in diabetes: Key learnings for cardiologist
觀看內容
Cardiologist Practical Guide to Prescribing
資訊圖表
Cardiologist Practical Guide to Prescribing
觀看內容
Safety and tolerability of SGLT2 inhibitors – how and when should I initiate treatment
影片
Safety and tolerability of SGLT2 inhibitors – how and when should I initiate treatment
觀看內容
Cardiorenal benefits of SGLT2 inhibitors
簡報
Cardiorenal benefits of SGLT2 inhibitors
觀看內容
Diagnosis and co-morbidities of chronic kidney disease
影片
Diagnosis and co-morbidities of chronic kidney disease
觀看內容